Although imperfect as a measure of HPA activity, a single morning serum cortisol may still predict metabolic disease risk, as we have shown that higher morning serum cortisol is associated with the presence of metabolic syndrome cross-sectionally [28] and with deterioration of insulin sensitivity over time [29] in our study population. This evidence concerns the gene INS and metabolic disease.